Organigram Global Inc. · TSX:OGI
Organigram Global — Investor Presentation (January 2021)
23 slides from Organigram Global's investor presentation, Jan 12, 2021
Slide 1: Organigram Investor Presentation
ORGANIGRAM INVESTOR PRESENTATION NASDAQ (OGI) TSX (OGI)
Slide 2: Cautionary Statement
CAUTIONARY STATEMENT This document is current as of January 11, 2021, except where otherwise stated. The information and the sufficiency of the retail networks to supply such demand; ability to enter and participate in contained in this presentation is provided by Organigram (“OGI” or the “Company”)
Slide 3: Organigram at a Glance
ORGANIGRAM AT A GLANCE LEADING LICENSED 3 LEVEL INDOOR CANADIAN INNOVATION PRODUCER GROWING PROVINCES Focused on Leading licensed Indoor facility in Sales to all continuous producer (LP) Moncton, NB with 10 Canadian improvement, of quality products for unique three-level provinces innovation and Med
Slide 4: Q1 Fiscal 2021 Key Financial Highlights
Q1 FISCAL 2021 KEY FINANCIAL HIGHLIGHTS Generated positive cash Double digit % growth in adult-use recreational market flow from operations revenue (CFO) in Q1 F2021 ADULT-USE REC GROSS REVENUE ADULT-USE REC NET REVENUE ADULT-USE REC GROSS REVENUE ADULT-USE REC • 2nd quarter of the last NET REVE
Slide 5: Three Level Indoor Cultivation
THREE LEVEL INDOOR CULTIVATION • 3 levels of growing maximizes footprint • Control all critical facets TECHNOLOGY of environment with state-of-the-art technology and innovation • Data driven decisions 1 3 levels of growing maximizes footprint 2 Control all critical facets of environment with state-o
Slide 6: Organigram Adult Use Recreational Brands
ORGANIGRAM ADULT USE RECREATIONAL BRANDS #1 MOST SEARCHED One of top 12 BRAND MOST-SEARCHED brands on MOST SEARCHED for November and Ontario Cannabis Store website for November 2020 December 2020 Pricing Value Value Value Segment Mainstream Whole Flower, Whole Flower, Available / Pre-Milled Flower,
Slide 7: Product Portfolio Revitalization
PRODUCT PORTFOLIO REVITALIZATION Q4 F2020 Q1 F2021 Q2 F2021 53 NEW SKUS LAUNCHED FLOWER Up to 14 Edison 3.5g Black Cherry Punch, FLOWER FLOWER FLOWER Limited Time Offers DISSOLVABLE I.C.C. Buds 28g Edison new high SHRED RE:Mix launch in Ontario THC strains pre-shredded FLOWER Trailblazer Dissolvable
Slide 8: OGI Vaporizer Pen Portfolio
REC 2.0 OGI VAPORIZER PEN PORTFOLIO • Vape portfolio includes offerings for value, mainstream and premium segments of the market • Selected as one of the Canadian partners for PAX ERA, the premium closed loop vaporizer system created by PAX Labs, Inc. • Selected as exclusive Canadian supplier of Fea
Slide 9: Cannabis-Infused Chocolates
REC 2.0 CANNABIS-INFUSED CHOCOLATES • ~$15M investment in high-speed, high-capacity, fully-automated production line that includes advanced engineering, robotics, high-speed labeling, automated carton packing • Launched first product in February 2020, Edison Bytes, premium truffles in milk and dark
Slide 10: Edison Re:Mix
REC 2.0 PROPRIETARY NANOEMULSIFICATION TECHNOLOGY EDISON RE:MIX • Proprietary nanoemulsion technology developed by internal R&D team • Nanoemulsion offers improved absorption when compared to traditional edibles and beverages • Customizable: can easily be added to almost any beverage • Rapid: dissol
Slide 11: Leafly Readers Choice Award Winners
LEAFLY READERS CHOICE AWARD WINNERS Products from our Edison Cannabis Co. Brand have been chosen as the best in Canada! TOP THC-DOMINANT FLOWER TOP PRE-ROLL TOP CBD OIL TOP THC OIL LA STRADA EL DORADO PRE-ROLL EDISON CBD EDISON SATIVA Mentions: Top Licensed Producer, #2 Top Balanced Oil, #3 Top Pre-
Slide 12: Investment in Disruptive Technology-Biosynthesis
INVESTMENT IN DISRUPTIVE TECHNOLOGY-BIOSYNTHESIS • Investment in Hyasynth, a biotech company and leader in the field of cannabinoid science and biosynthesis BIOSYNTHESIS • Hyasynth’s biosynthesis process uses patent-pending yeast strains and How it works? A proprietary enzymes to produce pure cannab
Slide 13: OGI's Largest International Deal to Date
OGI’S LARGEST INTERNATIONAL DEAL TO DATE • On June 9, 2020, entered into a multi-year agreement for supply of dried flower to one of Israel’s largest and most established medical cannabis producers, Canndoc Ltd., a pioneer in pharmaceutical-grade cannabis for > 12 years • Canndoc’s GMP-approved medi
Slide 14: Liquidity and Capital Resources
LIQUIDITY AND CAPITAL RESOURCES • Generated positive cash flow from operations of $0.3 million in Q1 Fiscal 2021 • On the back of strong institutional support, opportunistically raised $69 million in gross proceeds from an underwritten public offering • On November 27, 2020, amended the credit facil
Slide 15: Canadian Adult-Use Rec Market Size and Growth
CANADIAN ADULT-USE REC MARKET SIZE AND GROWTH NUMBER OF CANNABIS RETAIL STORES NUMBER OF ONTARIO RETAIL STORE AUTHORIZATIONS PER MONTH Jul- Jan- 2020 2021 Ontario Sept-2020 Today* RECORD Ontario $3.2B 102 330 Rest of Rest of Canadian Canadian MARKET provinces provinces 861 1034 Annualized run rate1
Slide 16: Appendix
APPENDIX
Slide 17: A high-quality cannabis brand
A high-quality cannabis brand. Limelight 3.5g | 7g | 15 g | Prerolls Bytes Milk Chocolate Remix Powder CBD:THC Pax Distillate 0.5 g Feather Distillate 0.3 g 16
Slide 18: A cannabis brand designed in celebration of progress
A cannabis brand designed in celebration of progress and the road less travelled. Freeze 28 g Torch Distillate 0.5 g | 1 g Buds 3.5g | 7g | 15 g | Prerolls Snax Mint Chocolate 17
Slide 19: Designed to break down the barriers to purchasing
Designed to break down the barriers to purchasing in the legal realm: price and convenience. Shred 7g | 15 g 18
Slide 20: Key Full Year Fiscal 2020 Financial Metrics
KEY FULL YEAR FISCAL 2020 FINANCIAL METRICS SELECT KEY FINANCIAL METRICS (IN $000S) unless otherwise indicated Fiscal 2020 Fiscal 2019 Gross revenue 103,387 97,547 Excise taxes (16,592) (17,134) Net revenue 86,795 80,413 Cost of sales 105,004 42,521 Gross margin before fair value changes to biologic
Slide 21: Key Full Year Fiscal 2020 Balance Sheet and Share Metrics
KEY FULL YEAR FISCAL 2020 BALANCE SHEET and SHARE METRICS SELECT BALANCE SHEET METRICS (IN $000S) 31-Aug-20 31-Aug-19 Cash & short-term investments 74,728 47,935 Biological assets & inventories 71,759 113,796 Other current assets 23,717 34,550 Accounts payable & other current liabilities 29,081 43,8
Slide 22: Q1 Fiscal 2021 Key Financial Metrics
Q1 FISCAL 2021 KEY FINANCIAL METRICS Select Key Financial Metrics (in $000s) unless otherwise Q1 2021 Q1 2020 % Change indicated Gross revenue 25,280 28,448 -11% Excise taxes (5,949) (3,295) 81% Net revenue 19,331 25,153 -23% Cost of sales 23,173 15,811 47% Gross margin before fair value changes to
Slide 23: Q1 Fiscal 2021 Key Balance Sheet and Share Metrics
Q1 FISCAL 2021 KEY BALANCE SHEET and SHARE METRICS Select Balance Sheet Metrics (in $000s) 30-Nov-20 31-Aug-20 % Change Cash & short-term investments 133,900 74,728 79% Biological assets & inventories 53,921 71,759 -25% Other current assets 20,556 23,717 -13% Accounts payable & accrued liabilities 1
Organigram Global — Investor Presentation (January 2021) on 6ix